ERBİLGİN, Y. Et Al. 2019. Deep sequencing of BCR-ABL1 kinase domain mutations in chronic myeloid leukemia patients with resistance to tyrosine kinase inhibitors.. Leukemia & lymphoma , vol.60, no.1 , 200-207.

ERBİLGİN, Y., Eskazan, A. E., HATIRNAZ NG, Ö., SALİHOĞLU, A., ELVERDİ, T., Firtina, S., ... Tasar, O.(2019). Deep sequencing of BCR-ABL1 kinase domain mutations in chronic myeloid leukemia patients with resistance to tyrosine kinase inhibitors.. Leukemia & lymphoma , vol.60, no.1, 200-207.

ERBİLGİN, Yücel Et Al. "Deep sequencing of BCR-ABL1 kinase domain mutations in chronic myeloid leukemia patients with resistance to tyrosine kinase inhibitors.," Leukemia & lymphoma , vol.60, no.1, 200-207, 2019

ERBİLGİN, Yücel Et Al. "Deep sequencing of BCR-ABL1 kinase domain mutations in chronic myeloid leukemia patients with resistance to tyrosine kinase inhibitors.." Leukemia & lymphoma , vol.60, no.1, pp.200-207, 2019

ERBİLGİN, Y. Et Al. (2019) . "Deep sequencing of BCR-ABL1 kinase domain mutations in chronic myeloid leukemia patients with resistance to tyrosine kinase inhibitors.." Leukemia & lymphoma , vol.60, no.1, pp.200-207.

@article{article, author={Yücel ERBİLGİN Et Al. }, title={Deep sequencing of BCR-ABL1 kinase domain mutations in chronic myeloid leukemia patients with resistance to tyrosine kinase inhibitors.}, journal={Leukemia & lymphoma}, year=2019, pages={200-207} }